Maze Therapeutics
- Market cap
- 1.46B
- P/E (TTM)i
- -10.91
- P/Bi
- 3.22
- EPSi
- -2.66
- Div yieldi
- 0.00%
- 52W posi
- 14%
Anonymous reader poll. Unscientific, not investment advice.
Maze Therapeutics ended the session at 26.25, down 0.68%. That leaves the company valued at approximately 1.46B, the #2998 most valuable US-listed company we track. The trailing P/E of -10.98 is 149% below its five-year average of 22.60. Across 7 analysts the consensus rating is Buy, with an average price target of 61.43 (+134%). The shares sit 14% of the way up their 52-week range of 21.95 to 53.65.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 6 months.
- Recent price momentum is -12.9% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has risen to 10.2% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 26.43
- Open
- 26.30
- Day range
- 25.87 - 26.89
- Avg price
- 26.23
- Volume
- 823.90K
- Turnover
- 21.61M
- Turnover ratei
- 2.21%
- Volume ratioi
- 1.37
- Amplitudei
- 3.84%
- 52-week rangei
- 21.95 - 53.65
Valuation
- P/Ei
- -9.88
- P/E (TTM)i
- -10.91
- P/Bi
- 3.22
- EPSi
- -2.66
- Book value / shi
- 8.16
- Net profit
- -147.65M
- Net assets
- 453.11M
Share structure
- Market cap
- 1.46B
- Float capi
- 977.82M
- Shares out
- 55.55M
- Float sharesi
- 37.25M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2025-01-31
51.1% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+6.93M net over the window
Short interest
- Shares short
- 5.68M
- % of floati
- 10.22%
- Days to coveri
- 10.40
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Maze Therapeutics (MAZE)?
Maze Therapeutics last traded at 26.25. The quote on this page refreshes every few seconds while US markets are open.
What is Maze Therapeutics's market cap?
About 1.46B.
What is the P/E ratio of Maze Therapeutics?
The trailing twelve-month P/E is -10.91, below its own 5-year average of 22.60 — in the middle of its historical range (54.93% percentile). See the Valuation tab for the full history.
Does Maze Therapeutics pay a dividend?
Maze Therapeutics does not currently pay a regular dividend.
Is Maze Therapeutics a buy according to analysts?
The consensus of 7 analysts is a Buy rating, with an average 12-month price target of 61.43, which implies 134.0% upside from the current price. This is not investment advice.
What is Maze Therapeutics's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Maze Therapeutics a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-10-08 04:44:40 · For reference only, not investment advice and not tailored to your situation.